Fact Check: CDC's 2025 funding is months late, risking vital public health programs.

Fact Check: CDC's 2025 funding is months late, risking vital public health programs.

Published June 29, 2025
±
VERDICT
Partially True

# Fact Check: "CDC's 2025 funding is months late, risking vital public health programs." ## What We Know The claim that the CDC's funding for 2025 is...

Fact Check: "CDC's 2025 funding is months late, risking vital public health programs."

What We Know

The claim that the CDC's funding for 2025 is delayed is supported by reports from multiple sources. According to a statement from the CDC, the Biden-Harris Administration released the President’s Budget for Fiscal Year 2025, requesting $9.683 billion, which is an increase from the previous year. However, there are indications that the actual disbursement of these funds is not occurring as scheduled. Reports from NPR highlight that CDC staff have noted the funding is "months late," which has led to significant operational challenges for state and local health departments that rely on these funds for various public health initiatives (NPR).

Furthermore, the NPR report indicates that the CDC has been operating with only 30 days of funding at a time, which has created uncertainty and risk for ongoing public health programs. This situation has been described as "rescission by inertia," suggesting that the delays are not merely administrative but have substantial implications for public health operations (NPR).

Analysis

The evidence suggests that while the CDC has proposed a budget increase for FY 2025, the actual funding process has encountered significant delays. The NPR report cites anonymous CDC staff who express concern over the lack of timely funding disbursement, which is critical for state and local health departments that depend on this funding for their operations. The characterization of the funding process as "months late" is corroborated by multiple sources, indicating a systemic issue within the funding mechanism (NPR).

However, the CDC's official statement emphasizes their commitment to public health and outlines the intended uses of the proposed budget, which includes addressing health threats and supporting mental health initiatives (CDC). This indicates that while the funding request is in place, the execution and timely distribution of these funds are where the problems lie.

In evaluating the reliability of the sources, the CDC's statement is an official government release, which typically carries a high degree of credibility. In contrast, the NPR report, while based on insider information, relies on unnamed sources, which can introduce uncertainty regarding the specifics of the claims. Nonetheless, NPR is generally regarded as a reputable news organization, and the concerns raised align with broader discussions about public health funding challenges in the U.S. (NPR, Medicine to Market).

Conclusion

The claim that the CDC's 2025 funding is delayed and risks vital public health programs is Partially True. While the CDC has proposed a significant budget increase, the actual disbursement of funds has been delayed, leading to operational challenges for local health departments. The situation reflects a disconnect between budget proposals and the timely execution of funding, which is critical for maintaining public health initiatives.

Sources

  1. CDC Statement on the President's Fiscal Year 2025
  2. CDC sources say its funding is coming at 'eyedropper' pace ... - NPR
  3. White House Budget Proposal: Major Cuts to NIH and CDC Signals Shift in ...

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: CDC's funding for 2025 is months late, risking public health programs.
False
🎯 Similar

Fact Check: CDC's funding for 2025 is months late, risking public health programs.

Detailed fact-check analysis of: CDC's funding for 2025 is months late, risking public health programs.

Jun 29, 2025
Read more →
Fact Check: CDC's 2025 funding is months late, risking public health projects.
Needs Research
🎯 Similar

Fact Check: CDC's 2025 funding is months late, risking public health projects.

Detailed fact-check analysis of: CDC's 2025 funding is months late, risking public health projects.

Jun 29, 2025
Read more →
Fact Check: Local health departments are in crisis due to CDC's funding confusion.
True
🎯 Similar

Fact Check: Local health departments are in crisis due to CDC's funding confusion.

Detailed fact-check analysis of: Local health departments are in crisis due to CDC's funding confusion.

Jun 29, 2025
Read more →
Fact Check: Health and Human Services Secretary Robert F. Kennedy Jr. ordered changes to the CDC's vaccine recommendations in May 2025, excluding children and pregnant women without underlying health conditions.
True

Fact Check: Health and Human Services Secretary Robert F. Kennedy Jr. ordered changes to the CDC's vaccine recommendations in May 2025, excluding children and pregnant women without underlying health conditions.

Detailed fact-check analysis of: Health and Human Services Secretary Robert F. Kennedy Jr. ordered changes to the CDC's vaccine recommendations in May 2025, excluding children and pregnant women without underlying health conditions.

Jun 17, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: CDC's 2025 funding is months late, risking vital public health programs. | TruthOrFake Blog